These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 3788760)
41. Accessory atrioventricular pathways with only antegrade conduction in patients with symptomatic Wolff-Parkinson-White syndrome. Clinical features, electrophysiological characteristics and response to radiofrequency catheter ablation. Tai CT; Chen SA; Chiang CE; Wu TJ; Cheng CC; Chiou CW; Lee SH; Ueng KC; Chang MS Eur Heart J; 1997 Jan; 18(1):132-9. PubMed ID: 9049525 [TBL] [Abstract][Full Text] [Related]
42. Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern. Fukatani M; Tanigawa M; Mori M; Konoe A; Kadena M; Shimizu A; Hashiba K Jpn Circ J; 1990 Oct; 54(10):1331-9. PubMed ID: 2277412 [TBL] [Abstract][Full Text] [Related]
43. Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Hindricks G; Kottkamp H; Chen X; Willems S; Breithardt G; Borggrefe M Eur Heart J; 1995 Jul; 16(7):967-70. PubMed ID: 7498213 [TBL] [Abstract][Full Text] [Related]
44. Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff-Parkinson-White syndrome. Wu JT; Zhao DQ; Li FF; Zhang LM; Hu J; Fan XW; Hu GL; Yang HT; Yan LJ; Liu JJ; Xu XJ; Wang SL; Chu YJ Clin Cardiol; 2020 Dec; 43(12):1511-1516. PubMed ID: 33002216 [TBL] [Abstract][Full Text] [Related]
45. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Morady F; Sledge C; Shen E; Sung RJ; Gonzales R; Scheinman MM Am J Cardiol; 1983 Jun; 51(10):1623-8. PubMed ID: 6858868 [TBL] [Abstract][Full Text] [Related]
46. Radiofrequency catheter ablation of atrioventricular accessory pathways in Wolff-Parkinson-White syndrome with drug-refractory and symptomatic supraventricular tachycardia--its high effectiveness irrespective of accessory pathway location and properties. Iesaka Y; Takahashi A; Chun YH; Igawa M; Tokunaga T; Amemiya H; Fujiwara H; Aonuma K; Nogami A; Hiroe M Jpn Circ J; 1994 Oct; 58(10):767-77. PubMed ID: 7966998 [TBL] [Abstract][Full Text] [Related]
47. Late cure after radiofrequency catheter ablation in a pediatric patient. Sarubbi B; D'Alto M; Calvanese R; Russo MG; CalabrĂ² R J Cardiovasc Med (Hagerstown); 2006 May; 7(5):356-61. PubMed ID: 16645415 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Ludmer PL; McGowan NE; Antman EM; Friedman PL J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response. Critelli G; Gallagher JJ; Perticone F; Coltorti F; Monda V; Condorelli M Am Heart J; 1984 Oct; 108(4 Pt 1):905-9. PubMed ID: 6486001 [TBL] [Abstract][Full Text] [Related]
51. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation. Paul T; Guccione P; Garson A Am J Cardiol; 1990 Feb; 65(5):318-21. PubMed ID: 2301260 [TBL] [Abstract][Full Text] [Related]
52. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome. Rinkenberger RL; Naccarelli GV; Miles WM; Markel ML; Dougherty AH; Prystowsky EN; Heger JJ; Zipes DP Am J Cardiol; 1988 Dec; 62(19):26L-30L. PubMed ID: 3144164 [TBL] [Abstract][Full Text] [Related]
53. Catheter ablation of accessory pathways in patients with Wolff-Parkinson-White syndrome. Gaita F; Richiardi E; Giustetto C; Bocchiardo M; Scaglione M; Zola G; Libero L; Riccardi R G Ital Cardiol; 1992 Nov; 22(11):1245-53. PubMed ID: 1297610 [TBL] [Abstract][Full Text] [Related]
54. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964 [TBL] [Abstract][Full Text] [Related]
55. Atrial and ventricular vulnerability in a patient with the Wolff-Parkinson-White syndrome. Peters RW; Gonzalez R; Scheinman MM Pacing Clin Electrophysiol; 1981 Jan; 4(1):17-22. PubMed ID: 6171787 [TBL] [Abstract][Full Text] [Related]
56. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome. Swerdlow CD; Peterson J; Liem LB Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome. Cagli KE; Topaloglu S; Aras D; Sen N; Akpinar I; Durak A; Kisacik HL J Interv Card Electrophysiol; 2009 Dec; 26(3):217-24. PubMed ID: 19844784 [TBL] [Abstract][Full Text] [Related]
58. Ventricular preexcitation following catheter ablation of the His bundle in concealed WPW syndrome. Steinbeck G; Bach P; Haberl R; Markewitz A Eur Heart J; 1986 May; 7(5):444-8. PubMed ID: 3732294 [TBL] [Abstract][Full Text] [Related]
59. [Comparison of clinical and electrophysiologic characteristics of patients with occult and manifest atrioventricular accessory pathway]. Bottoni N; Donateo P; Tomasi C; Lolli G; Oddone D; Croci F; Menozzi C; Brignole M Ital Heart J Suppl; 2001 Aug; 2(8):888-93. PubMed ID: 11582721 [TBL] [Abstract][Full Text] [Related]
60. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. Bromberg BI; Lindsay BD; Cain ME; Cox JL J Am Coll Cardiol; 1996 Mar; 27(3):690-5. PubMed ID: 8606283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]